comparemela.com

Hemispherian As News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hemispherian raises the first tranche of a Series A to fund the development of its novel cancer therapeutics

/PRNewswire/ Hemispherian AS ("Hemispherian" or the "Company"), a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics.

Hemispherian Secures EUR 10M in Financing from the European Innovation Council (EIC) Accelerator Program

/PRNewswire/ Hemispherian AS ("Hemispherian or the "Company"), a Norwegian preclinical pharmaceutical company focused on small molecule cancer.

Hemispherian raises seed funding for novel cancer therapeutics

/PRNewswire/ Hemispherian AS ("Hemispherian" or the "Company"), a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.